Report Detail

Request for Sample of this report

Pharma & Healthcare Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Growth 2019-2024

  • RnM2906492
    • |
  • 08 February, 2019
    • |
  • Global
    • |
  • 164 Pages
    • |
  • LPI(LP Information)
    • |
  • Pharma & Healthcare

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.

According to this study, over the next five years the Liposome Drug Delivery (Liposomes Drug Delivery) market will register a 12.8% CAGR in terms of revenue, the global market size will reach US$ 4750 million by 2024, from US$ 2600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Liposome Drug Delivery (Liposomes Drug Delivery) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Drug Delivery (Liposomes Drug Delivery) market by product type, application, key manufacturers and key regions and countries.

This study considers the Liposome Drug Delivery (Liposomes Drug Delivery) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Fungal Infection Therapy
Cancer & Tumor Therapy
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Liposome Drug Delivery (Liposomes Drug Delivery) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Liposome Drug Delivery (Liposomes Drug Delivery) market by identifying its various subsegments.
Focuses on the key global Liposome Drug Delivery (Liposomes Drug Delivery) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Liposome Drug Delivery (Liposomes Drug Delivery) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Liposome Drug Delivery (Liposomes Drug Delivery) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2014-2024
        • 2.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption CAGR by Region
      • 2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Type
        • 2.2.1 Liposomal Doxorubicin
        • 2.2.2 Liposomal Amphoteracin B
        • 2.2.3 Liposomal Paclitaxel
        • 2.2.4 Others
      • 2.3 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
        • 2.3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Type (2014-2019)
      • 2.4 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Application
        • 2.4.1 Fungal Infection Therapy
        • 2.4.2 Cancer & Tumor Therapy
        • 2.4.3 Others
      • 2.5 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
        • 2.5.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Application (2014-2019)

      3 Global Liposome Drug Delivery (Liposomes Drug Delivery) by Players

      • 3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Players
        • 3.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Players (2017-2019)
        • 3.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Players (2017-2019)
      • 3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Players
        • 3.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Players (2017-2019)
        • 3.2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Players (2017-2019)
      • 3.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Players
      • 3.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Liposome Drug Delivery (Liposomes Drug Delivery) by Regions

      • 4.1 Liposome Drug Delivery (Liposomes Drug Delivery) by Regions
        • 4.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Regions
        • 4.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Value by Regions
      • 4.2 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth
      • 4.3 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth
      • 4.4 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth
      • 4.5 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth

      5 Americas

      • 5.1 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries
        • 5.1.1 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2014-2019)
        • 5.1.2 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2014-2019)
      • 5.2 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
      • 5.3 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries
        • 6.1.1 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2014-2019)
        • 6.1.2 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2014-2019)
      • 6.2 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
      • 6.3 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
        • 7.1.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2014-2019)
        • 7.1.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2014-2019)
      • 7.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
      • 7.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
        • 8.1.1 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
      • 8.3 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Liposome Drug Delivery (Liposomes Drug Delivery) Distributors
      • 10.3 Liposome Drug Delivery (Liposomes Drug Delivery) Customer

      11 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast

      • 11.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2024)
      • 11.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Forecast by Regions
        • 11.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Forecast by Regions (2019-2024)
        • 11.2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Liposome Drug Delivery (Liposomes Drug Delivery) Forecast by Type
      • 11.8 Global Liposome Drug Delivery (Liposomes Drug Delivery) Forecast by Application

      12 Key Players Analysis

      • 12.1 Gilead Sciences
        • 12.1.1 Company Details
        • 12.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.1.3 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Gilead Sciences News
      • 12.2 Pacira
        • 12.2.1 Company Details
        • 12.2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.2.3 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Pacira News
      • 12.3 Sun Pharmaceutical
        • 12.3.1 Company Details
        • 12.3.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.3.3 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Sun Pharmaceutical News
      • 12.4 Johnson & Johnson
        • 12.4.1 Company Details
        • 12.4.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.4.3 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Johnson & Johnson News
      • 12.5 Luye Pharma
        • 12.5.1 Company Details
        • 12.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.5.3 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Luye Pharma News
      • 12.6 Sigma-Tau Group
        • 12.6.1 Company Details
        • 12.6.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.6.3 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Sigma-Tau Group News
      • 12.7 Ipsen (Onivyde)
        • 12.7.1 Company Details
        • 12.7.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.7.3 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Ipsen (Onivyde) News
      • 12.8 CSPC
        • 12.8.1 Company Details
        • 12.8.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.8.3 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 CSPC News
      • 12.9 Teva Pharmaceutical
        • 12.9.1 Company Details
        • 12.9.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.9.3 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Teva Pharmaceutical News
      • 12.10 Novartis
        • 12.10.1 Company Details
        • 12.10.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
        • 12.10.3 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Novartis News
      • 12.11 Fudan-Zhangjiang

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Liposome Drug Delivery (Liposomes Drug Delivery) . Industry analysis & Market Report on Liposome Drug Delivery (Liposomes Drug Delivery) is a syndicated market report, published as Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Liposome Drug Delivery (Liposomes Drug Delivery) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,660.00
      		$5,490.00
      		$7,320.00
      		2,909.70
      		4,364.55
      		5,819.40
      		3,385.50
      		5,078.25
      		6,771.00
      		572,497.20
      		858,745.80
      		1,144,994.40
      		305,719.80
      		458,579.70
      		611,439.60
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo